Alu elements, parts of our DNA once considered useless, have been found to contribute to various diseases, including cancer. Researchers have been studying how these elements, especially free Alu RNAs, contribute to diseases like cancer. A recent study led by Dr. Valeria Tarallo focused on the impact of Alu RNAs on colorectal cancer. The research involved experiments on cancer cell lines (cells grown in a lab for study) and analysis of human tissue samples. The study aimed to explore how Alu RNAs cause changes in cells that lead to cancer progression. The researchers demonstrated that cancer cells released Alu RNAs via exosomes, which are extracellular vesicles involved in intercellular communication, and this release promotes tumorigenesis. The findings suggest that Alu RNAs could be used as biomarkers for CRC diagnosis and might offer new targets for therapy. This summary was initially drafted using artificial intelligence, then revised and fact-checked by the author.
Cancer-derived exosomal Alu RNA promotes colorectal cancer progression
Magliacane Trotta S.Primo
;Mercadante G.;De Falco S.Co-ultimo
;Tarallo V.
2024
Abstract
Alu elements, parts of our DNA once considered useless, have been found to contribute to various diseases, including cancer. Researchers have been studying how these elements, especially free Alu RNAs, contribute to diseases like cancer. A recent study led by Dr. Valeria Tarallo focused on the impact of Alu RNAs on colorectal cancer. The research involved experiments on cancer cell lines (cells grown in a lab for study) and analysis of human tissue samples. The study aimed to explore how Alu RNAs cause changes in cells that lead to cancer progression. The researchers demonstrated that cancer cells released Alu RNAs via exosomes, which are extracellular vesicles involved in intercellular communication, and this release promotes tumorigenesis. The findings suggest that Alu RNAs could be used as biomarkers for CRC diagnosis and might offer new targets for therapy. This summary was initially drafted using artificial intelligence, then revised and fact-checked by the author.File | Dimensione | Formato | |
---|---|---|---|
2024-03 Trotta_et_al-Experimental_&_Molecular_Medicine.pdf
accesso aperto
Tipologia:
Versione Editoriale (PDF)
Licenza:
Creative commons
Dimensione
2.78 MB
Formato
Adobe PDF
|
2.78 MB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.